Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Chrono Therapeutics

3953 Point Eden Way
Hayward, CA 94545
USA
Website Company Summary Management Team
Management

General Management: Patricia A Oto
Technology: David Evans Roth (7/31/2014)
Sales/Marketing: Jenny Hapgood
Board

Outside board: (May no longer be on the board) Wende Hutton (Canaan Partners General Partner) Aiden King (Fountain Healthcare Partners) James W Young (5AM Ventures Venture Partner)
Company

Business description: Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products. Steeped with years of experience in product development, science, R&D an understanding of the consumer smoking cessation market, FDA approval experience and bringing life-saving products to market, the team represents a wide-array of knowledge that combined can help address the serious epidemic of smoking. SmartStop is a wearable device that offers programmable, transdermal nicotine replacement therapy (NRT) in combination with real-time behavioral support. SmartStop is designed to automatically vary nicotine levels throughout the day to match those patterns. The device uses Bluetooth technology to wirelessly communicate with the SmartStop digital support program, providing real-time guidance to help smokers cope with cravings as well as a means for promoting compliance to the NRT and overall quit process.
Capital

Rounds: 2
Recent Fundings: Sep 2016   Jun 2014
Capital raised: 82.0M
Last Round: 47.6M
Ownership: Private  
VCs include: Canaan Partners5AM VenturesEmergent Medical Partners Mission Bay Capital ;  Endeavour Vision ;  Fountain Healthcare Partners;  Cota Capital ;  Hikma Ventures ;  Xeraya Capital
Corporate investors: Kaiser Permanente Ventures GE Ventures;  Labuan ;  Asahi Kasei
Other investors: Mayo Clinic

Last Tweets


 

Last Mentions


Overview
Record updated: Feb 2018
Sector: Medical
Year Founded: 2004
Headcount: 26-50 as of Jan 2019
Rounds: 2
Recent Fundings: Sep 2016   Jun 2014
Capital Raised: 82.0M
Last Round: 47.6M
Ownership: Private